National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.4)
Instrument number PB 27 of 2011
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated                 28                March  2011
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.4).
         (2)   This Determination may also be cited as PB 27 of 2011.
2              Commencement
                This Determination commences on 1 April 2011.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
[1]     Schedule 1, after item dealing with Adalimumab
                  
Insert
 
          Adapalene with benzoyl peroxide
 
[2]     Schedule 1, after item dealing with Dutasteride
                  
Omit
 
           Dydrogesterone
 
[3]     Schedule 1, after item dealing with Ferrous sulphate
                  
Omit
 
                     Filgrastim
 
[4]     Schedule 1, after item dealing with Ibuprofen
                  
Omit
 
                    Idarubicin
 
[5]     Schedule 1, after item dealing with Pimecrolimus
                  
Omit
 
                    Pioglitazone
 
[6]     Schedule 1, after item dealing with Riluzole
                  
Omit
 
                    Risedronic acid
 
[7]     Schedule 1, after item dealing with Rizatriptan
                  
Insert
 
                    Romiplostim
 
[8]     Schedule 1, after item dealing with Sitagliptin
                  
Omit
 
                    Sitaxentan
 
[9]     Schedule 1, after item dealing with Zolmitriptan
                  
                   Omit
 
                    Zuclopenthixol decanoate
 
Insert
 
                    Zonisamide
 
[10]   Schedule 2, after item dealing with Felodipine
                  
Insert
 
          Filgrastim
 
[11]   Schedule 2, after item dealing with Hypromellose with dextran
                  
Insert
 
          Idarubicin
 
 
[12]   Schedule 2, after item dealing with Pindolol
                  
Insert
 
          Pioglitazone
 
[13]   Schedule 2, after item dealing with Ranitidine
                  
Insert
 
          Risedronic acid
 
 
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.